View allAll Photos Tagged stemcell
The University of Louisville Division of Cardiovascular Medicine presented the 21st Annual Leonard Leight Lecture on December 10, 2014 in Kornhauser Auditorium on the UofL Health Sciences campus.
The special guest speaker for 2014 was Victor J. Dzau, M.D., President of the Institute of Medicine.
Dr. Dzau presented "Molecular Approaches to Cardiac Regeneration" focusing on understanding cell-based therapy for cardiac regeneration.
Bệnh viện Quốc tế DNA chuyên cung cấp dich vụ chữa bệnh và là m đẹp trẻ hóa cơ thể toà n diện bằng tế bà o gốc vạn năng
Lledó Martà Urrea, Legal and Health Policy Adviser, Regional Office of Valencia
What is the state of R&D, funding, and infrastructure in Europe? This Science|Business Policy Roundtable took place at the UK Representation to the EU in Brussels on 18 October 2012.
Regenerative Medicine is one of the most exciting and promising fields of biomedical research today. Europe currently leads the world in therapeutic applications and medicines in this technology, and has successfully seen the first companies working in the field to spin-out from research universities with EMA approved products currently in the market.
However, with the recent patent ruling by the European Court of Justice and the debate regarding continued funding in Horizon 2020, what challenges exist for Europe to maintain its research lead in this field?
Science|Business hosted a roundtable discussion of thought leaders and policy to make recommendations as to what the EU should do to improve the infrastructure and research climate for new stem cell technologies and regenerative medicines in Europe.
Pictures by Carlos Nomen
A) Eye Release Factor Effect on non-treated eye. B) Eye injected with RPE stem cells. C) No injection in either eye..
This was our worst day. Lots of pokes and 3 blown veins. Ellie was having growth hormone stemcell testing. Love her!
Ruth McKernan, Chief Scientific Officer, Neusentis, Pfizer
What is the state of R&D, funding, and infrastructure in Europe? This Science|Business Policy Roundtable took place at the UK Representation to the EU in Brussels on 18 October 2012.
Regenerative Medicine is one of the most exciting and promising fields of biomedical research today. Europe currently leads the world in therapeutic applications and medicines in this technology, and has successfully seen the first companies working in the field to spin-out from research universities with EMA approved products currently in the market.
However, with the recent patent ruling by the European Court of Justice and the debate regarding continued funding in Horizon 2020, what challenges exist for Europe to maintain its research lead in this field?
Science|Business hosted a roundtable discussion of thought leaders and policy to make recommendations as to what the EU should do to improve the infrastructure and research climate for new stem cell technologies and regenerative medicines in Europe.
Pictures by Carlos Nomen
ReeLabs is one of the most trusted and best Stem Cell bank in Mumbai- AABB certified. We also offer stem cell preservation and therapy at our treatment facility, ReeLabs, at Mumbai India
Duane Schulthess, Commercial Director, Science|Business
What is the state of R&D, funding, and infrastructure in Europe? This Science|Business Policy Roundtable took place at the UK Representation to the EU in Brussels on 18 October 2012.
Regenerative Medicine is one of the most exciting and promising fields of biomedical research today. Europe currently leads the world in therapeutic applications and medicines in this technology, and has successfully seen the first companies working in the field to spin-out from research universities with EMA approved products currently in the market.
However, with the recent patent ruling by the European Court of Justice and the debate regarding continued funding in Horizon 2020, what challenges exist for Europe to maintain its research lead in this field?
Science|Business hosted a roundtable discussion of thought leaders and policy to make recommendations as to what the EU should do to improve the infrastructure and research climate for new stem cell technologies and regenerative medicines in Europe.
Pictures by Carlos Nomen
Tanjungpinang atau Tanjung Pinang adalah ibu kota dari Provinsi Kepulauan Riau, Indonesia. Kota ini terletak di Pulau Bintan dan beberapa pulau kecil seperti Pulau Dompak dan Pulau Penyengat, dengan koordinat 0ยบ5' LU dan 104ยบ27' BT. Kota Tanjungpinang dahulunya adalah pusat pemerintahan Kesultanan Riau-Lingga.
APA ITU PENYAKIT AUTOIMMUN?
Penyakit Auto Imun Adalah Suatu penyakit ketika sistem kekebalan tubuh menyerang sel-sel sehat. Bahayanya, penyakit autoimun ini bisa mengakibatkan kerusakan sel jaringan dalam tubuh dan menimbulkan peradangan serta mengakibatkan kondisi yang serius pada penderitanya, seperti gangguan pada tulang persendian, saraf, kelenjar, dan organ-organ penting lainnya
Hampir setiap provinsi di Indonesia warnya ada yang mengidap penyakit Autoimun, Salmon Ovary Peptide SOP100+ dan SOP Subarashi banyak dikirim untuk membantu pengobatan ke setiap daerah
Salmon Ovary Peptide Siap dikirim ke Setiap Kabupaten :
1). Kabupaten Bintan
2). Kabupaten Karimun
3). Kabupaten Kepulauan Anambas
4). Kabupaten Lingga
5). Kabupaten Natuna
6). Kota Batam
7). Kota Tanjungpinang
Jenis Penyakit Autoimun
Yang paling banyak dari 80jenis yang dikategorikan jenis penyakit autoimun adalah sebagai berikut :
Artritis reumatoid
Cenderung penyakit ini menggantu kesehatan anda dalam persendian disebut dengan gangguan inflamasi kronis. Jadi yang anda rasakan bisa nyeri sendi, Sendi bengkak, Sendi kemerahan, terasa hangat. Dua jenis arthritis yang paling umum ditemui adalah osteoarthritis (OA) dan rheumatoid arthritis (RA).
Ini sering disebut penyakit mematikan dalam kategorinya. Penyakit radang yang disebabkan ketika sistem kekebalan tubuh menyerang jaringannya sendiri. Pada gangguan penyakit ini, serangan lupus ini dapat memengaruhi organ-organ seperti seperti ginjal, kulit, sistem muskoskleletal, sistem kardiovaskular, sistem saraf pusat dan tepi, dan darah. Umur 15-45 cenderung di serang penyakit ini
Penyakit seliak
Penyakit ini terjadi pada orang yang sering bermasalah dengan diare dalam jangka panjang mempengaruhi usus kecil. Reaksi kekebalan terhadap konsumsi gluten, yaitu protein yang terkandung dalam gandum, jelai, dan gandum hitam.
Sindrom Sjรถgren
Penyakit ini cenderung di dominasi oleh wanita di atas umur 40tahun. Gangguan sistem kekebalan tubuh yang ditandai dengan mata kering dan mulut kering. Karena langsung mengganggu kelenjar penghasil cairan seperti kelenjar air liur dan air mata. Untuk mata ini ada yang merasa mata kering, rasa terbakar dan juga gatal.
Polimialgia Reumatika
Bermasalah pada bahu, leher, dan panggul, eits jangan-jangan gangguan inflamasi yang menyebabkan nyeri otot dan kekakuan di bahu dan pinggul, ini masuk kategori autoimun ini. Cenderung di derita oleh usia lanjut dan memang banyak terjadi karena peradangan dan infeksi.
Sklerosis multipel
Kalau anda sudah diperiksa dokter dan vonisnya berasalah dengan pelindung saraf, maka Suatu penyakit saat sistem kekebalan tubuh menggerogoti lapisan pelindung saraf (sklerosis multipel). sistem kekebalan tubuh mengeluarkan reaksi abnormal dan menyerang sistem saraf pusat, terutama otak.
Spondilitis ankilosa
Masih berhubungan dengan sendi-sendi besar. Peradangan kronis yang dapat menyebabkan menutupnya celah antar ruas tulang belakang, terjadinya penyakit bungkuk. Selain menyerang tulang belakang bisa juga bagian sendi tubuh lainnya, jika terus penyakitnya berlanjut.
Diabetes Tipe 1
Sudah sering kita dengar penyakit ini, tapi ada 2 jenis tipe 1 dan tipe 2. Tipe 1 termasuk suatu kondisi kronis saat pankreas memproduksi insulin sedikit atau tidak sama sekali. Ini bisa terjadi sejak usia dari anak-anak. Jadi prosesnya memang jangka panjang ya.
Alopesia Areata
Mungkin jarang terjadi dimana kebotakan terjadi hanya daerah terentu, apakah itu di atas kepala, disamping atau di belakang membentuk lingkaran, bisa juga tumpang tindih. Selain hanya kebotakan juga bisa terjadi gangguan emosional yang dapat menyebabkan gangguan kecemasan dan depresi
Arteritis temporalis
Penyakit yang terjadi sekitar kepala. Peradangan pembuluh darah, yang disebut arteri, di dalam dan di sekitar kulit kepala. Gejala berupa sakit kepala, nyeri rahang, gangguan penglihatan, demam, dan kelelahan. Diagnosis biasanya membutuhkan biopsi arteri temporal.
Radang pembuluh darah
Penyakit Peradangan pembuluh darah dalam medis disebut dengan vaskulitis yang menyebabkan perubahan dalam dinding pembuluh darah. Komplikasi vaskulitis meliputi: Kerusakan organ: Beberapa jenis vaskulitis parah bisa menyebabkan kerusakan pada organ utama. Gumpalan darah dan aneurisma: Gumpalan darah dapat terbentuk di pembuluh darah, menghalangi aliran darah.
Penyakit inilah yang di derita oleh anak ibu yang kita ceritakan paling awal tadi.
Obat Autoimun Alami
Sebenarnya pertanyaan yang paling banyak adalah, apakah penyakit autoimun ini bisa sembuh total? Menurut para medis bahwa penyakit ini mirip seperti penyakit diabetes atau hipertensi. Tidak bisa sembuh total tetapi pengidap penyakit tersebut bisa dikontrol kesehatannya dan tetap hidup seperti biasa.
Tentu berbahaya kalau dalam jangka waktu lama tidak ditangani dengan baik, karena itu perlu di kontrol dan di konsultasikan dengan dokter. Seiring dengan berjalannya waktu bisa dibantu dengan obat herbal untuk radang pembuluh darah yang disebut dengan medis Vaskulitis.
Salmon Ovary Peptide
Penyakit autoimun adalah kondisi ketika sistem kekebalan tubuh seseorang menyerang tubuhnya sendiri. Pada seseorang yang menderita penyakit autoimun, sistem kekebalan tubuhnya melihat sel tubuh yang sehat sebagai asing.
Salmon Ovary Peptide membantu tubuh untuk meregenerasi kembali sel-sel dalam tubuh yang sudah dirusak oleh imun itu sendiri. Salmon Ovary Peptide terbuat dari ikan Oncorhynchus Keta Salmon yang memiliki kandungan bahan aktif yang lebih tinggi dari plasenta manusia ataupun plasenta mamalia. Telah diteliti oleh para ahli di AFC Life Science yang berkolaborasi dengan ilmuwan terkemuka.
Sudah diakui oleh pemerintah Jepang dengan 3paten, salah satunya adalah Patent JP 3946238: Anti-Aging/Cell Regeneration Effect, untuk meregenerasi sel dan mengaktifkan kembali stemcell yang rusak di dalam tubuh. Semoga Manfaat Salmon Ovary Peptide semakin banyak dirasakan oleh para penderita autoimmun ini.
Cara Pemakaian / Minum SOP 100+ atau SOP Subarashi :
Taruh serbuk di bawah lidah paling bagus dikonsumsi pagi hari antara jam 5 sd jam 9 pagi setelah bangun tidur sebelum makan apapun.
Untuk menjaga kesehatan bisa konsumsi 1x1 per hari. Untuk penyembuhan sakit bisa di tambahkan dosis sampai 4x1 per hari, tergantung kondisi penyakit.
Agen /Distributor Resmi SOP 100+
Beli SOP 100+ atau SOP Subarashi
Mr. Eric, Hp. 0857 6780 7007
Whatsapp : 0878 9381 1922 atau
Manuela Tudosia, Adviser, Cord Blood Europe AISBL
What is the state of R&D, funding, and infrastructure in Europe? This Science|Business Policy Roundtable took place at the UK Representation to the EU in Brussels on 18 October 2012.
Regenerative Medicine is one of the most exciting and promising fields of biomedical research today. Europe currently leads the world in therapeutic applications and medicines in this technology, and has successfully seen the first companies working in the field to spin-out from research universities with EMA approved products currently in the market.
However, with the recent patent ruling by the European Court of Justice and the debate regarding continued funding in Horizon 2020, what challenges exist for Europe to maintain its research lead in this field?
Science|Business hosted a roundtable discussion of thought leaders and policy to make recommendations as to what the EU should do to improve the infrastructure and research climate for new stem cell technologies and regenerative medicines in Europe.
Pictures by Carlos Nomen
Jonathan Brenton, British Ambassador to Belgium
What is the state of R&D, funding, and infrastructure in Europe? This Science|Business Policy Roundtable took place at the UK Representation to the EU in Brussels on 18 October 2012.
Regenerative Medicine is one of the most exciting and promising fields of biomedical research today. Europe currently leads the world in therapeutic applications and medicines in this technology, and has successfully seen the first companies working in the field to spin-out from research universities with EMA approved products currently in the market.
However, with the recent patent ruling by the European Court of Justice and the debate regarding continued funding in Horizon 2020, what challenges exist for Europe to maintain its research lead in this field?
Science|Business hosted a roundtable discussion of thought leaders and policy to make recommendations as to what the EU should do to improve the infrastructure and research climate for new stem cell technologies and regenerative medicines in Europe.
Pictures by Carlos Nomen
Brian Krolicki, NV Lieutenant Governor - Cord Blood America's Las Vegas, NV Corporate Office and Lab Grand Opening Speech
Magda Chlebus, Director Science Policy, EFPIA
Jonathan Brenton, British Ambassador to Belgium
What is the state of R&D, funding, and infrastructure in Europe? This Science|Business Policy Roundtable took place at the UK Representation to the EU in Brussels on 18 October 2012.
Regenerative Medicine is one of the most exciting and promising fields of biomedical research today. Europe currently leads the world in therapeutic applications and medicines in this technology, and has successfully seen the first companies working in the field to spin-out from research universities with EMA approved products currently in the market.
However, with the recent patent ruling by the European Court of Justice and the debate regarding continued funding in Horizon 2020, what challenges exist for Europe to maintain its research lead in this field?
Science|Business hosted a roundtable discussion of thought leaders and policy to make recommendations as to what the EU should do to improve the infrastructure and research climate for new stem cell technologies and regenerative medicines in Europe.
Pictures by Carlos Nomen
Recently I discovered it's fairly easy to become a donator of stemcells for people with certain forms of cancer, so the decision for me was easy. I received the typing-kit, which they use to find a matching patient (chances are very slim that i'll ever get called upon though)
This did spark up some interesting discussions though, because not everyone feels inclined to become a donor. Which is ok with me, as long as they at least thought about it. So in this way i'm hoping to raise some awareness that it is possible to help people with cancer in ways other than just money.
For the Dutch: europdonor.nl/
(You can donate anywhere in the world, a lot of local agencies are connected to a worldwide database)
Adam Heathfield, Director Science Policy Europe, Pfizer
What is the state of R&D, funding, and infrastructure in Europe? This Science|Business Policy Roundtable took place at the UK Representation to the EU in Brussels on 18 October 2012.
Regenerative Medicine is one of the most exciting and promising fields of biomedical research today. Europe currently leads the world in therapeutic applications and medicines in this technology, and has successfully seen the first companies working in the field to spin-out from research universities with EMA approved products currently in the market.
However, with the recent patent ruling by the European Court of Justice and the debate regarding continued funding in Horizon 2020, what challenges exist for Europe to maintain its research lead in this field?
Science|Business hosted a roundtable discussion of thought leaders and policy to make recommendations as to what the EU should do to improve the infrastructure and research climate for new stem cell technologies and regenerative medicines in Europe.
Pictures by Carlos Nomen
Erik Tambuyzer, Managing Director, Center for Biomedical Innovation (CMI)
What is the state of R&D, funding, and infrastructure in Europe? This Science|Business Policy Roundtable took place at the UK Representation to the EU in Brussels on 18 October 2012.
Regenerative Medicine is one of the most exciting and promising fields of biomedical research today. Europe currently leads the world in therapeutic applications and medicines in this technology, and has successfully seen the first companies working in the field to spin-out from research universities with EMA approved products currently in the market.
However, with the recent patent ruling by the European Court of Justice and the debate regarding continued funding in Horizon 2020, what challenges exist for Europe to maintain its research lead in this field?
Science|Business hosted a roundtable discussion of thought leaders and policy to make recommendations as to what the EU should do to improve the infrastructure and research climate for new stem cell technologies and regenerative medicines in Europe.
Pictures by Carlos Nomen
Sometimes it takes a mother’s touch to soothe the scrapes and pains of growing up. But not even a mother’s love can completely erase the anguish of childhood diabetes.
Kim Hurshman and her two sons in Springfield, Missouri, know this as well as anyone does – Type 1 diabetes has been an unwelcome participant in both boys’ lives. Little did they know upon the first diagnosis the traumatic treatments that would follow.
Judging by the tears Mrs. Hurshman has shed for her children, the pain isn’t theirs alone.
Fortunately, scientists are working toward a cure. Visit www.MissouriCures.com to learn about the most recent advances – and how you can help protect medical research in Missouri.
Mr. Joseph Vicente, Chief Operating Officer of Cord Blood America, Inc., giving his speech at the Grand Opening of the company's new corporate office and lab in Las Vegas, Nevada on January 22, 2010.
Stem cell patch allows word-blind patients to read again: bit.ly/2u50Dkc #stemcells #science #tuesdaymotivation #tuesnews
Thomas Dentzer, Luxembourg BioHealth Cluster Manager, Luxinnovation
What is the state of R&D, funding, and infrastructure in Europe? This Science|Business Policy Roundtable took place at the UK Representation to the EU in Brussels on 18 October 2012.
Regenerative Medicine is one of the most exciting and promising fields of biomedical research today. Europe currently leads the world in therapeutic applications and medicines in this technology, and has successfully seen the first companies working in the field to spin-out from research universities with EMA approved products currently in the market.
However, with the recent patent ruling by the European Court of Justice and the debate regarding continued funding in Horizon 2020, what challenges exist for Europe to maintain its research lead in this field?
Science|Business hosted a roundtable discussion of thought leaders and policy to make recommendations as to what the EU should do to improve the infrastructure and research climate for new stem cell technologies and regenerative medicines in Europe.
Pictures by Carlos Nomen
For more information about the Ethics in a Science Classroom Workshop, please visit www.nwabr.org/teachers/ethics-science-classroom